BMY-21502
BMY-21502 (BMS-181168) is a pyrrolidinone derivative with memory- and cognition-enhancing activities. BMS-181168 attenuates hypoxia-induced deterioration in brain function, as delta/theta decreases, alpha activity increases and the centroid of the combined delta/theta waves is accelerated[1].
Product Specifications
CAS Number
[123259-91-6]
Product Name Alternative
BMS-181168
UNSPSC
12352005
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bmy-21502.html
Purity
98.98
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1N(CC2CCN(CC2)C3=NC(C(F)(F)F)=NC=C3)CCC1
Molecular Formula
C15H19F3N4O
Molecular Weight
328.33
References & Citations
[1]Saletu B, et al. BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies. Pharmacopsychiatry. 1994 Sep;27 (5) :189-97.|[2]Saletu B, et al. BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies. Pharmacopsychiatry. 1994 Sep;27 (5) :189-97.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
